Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
PaperCitations, authors & open-access status
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 3,424 citations, 2017 year and bronze oa status.
3,424
Citations
2017
Year
bronze
OA Status